Drawing for ABDIIBRAHIM

USPTO serial 79079797

ABDIIBRAHIM

Reviewed by CopyMark Law Group

Reg. 3899452Status 404
Filing date
Status date
Registration date
Jan 4, 2011
Examiner
BROWN, TINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ABDIIBRAHIM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aylin Demirci

Aylin Demirci Intellectual Property Law Group LLP12 South First Street12th FloorSan Jose, CA 95113

Goods and services

ClassDescriptionStatusFirst use
005Systemic anti-infectives, including, antibacterial and antifungal pharmaceuticals; Vitamin mineral preparations, namely, vitamin and mineral supplements, vitamin and mineral preparations for medical use, vitamin preparations and mineral supplements; Musculo-skeletal system pharmaceutical products for the treatment of musculo-skeletal system diseases; Cardiovascular pharmaceuticals, including, diuretics, lipid lowering agents, beta blocking agents, calcium antagonists and other cardiovascular products; Pharmaceuticals for the prevention and treatment of disorders of the nervous system, including, analgesics, psychoanaleptics, psycoleptics, anti-epileptics, central nervous system drugs, anaesthetics, antiparkinson preparations; Pharmaceuticals for the treatment of respiratory diseases and asthma; Dermatological pharmaceutical products; Pharmaceuticals for the treatment of hormonal disorders and the prevention of osteoporosis; Anti-diabetic pharmaceuticals; Pharmaceuticals for the treatment of bone diseases and joint diseases; Pharmaceuticals for the treatment of viral and infectious diseases; Pharmaceuticals for use as antineoplastic agents; Pharmaceuticals for the treatment of immune system related diseases and disorders; Pharmaceuticals for the treatment of kidney diseases; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals for ophthalmological useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 28, 2020DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 28, 2020DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 28, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 19, 2018INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 18, 2018XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Apr 18, 2018XXCRGENERIC MADRID TRANSACTION CREATED—
Apr 11, 2018INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 11, 2017C71TCANCELLED SECTION 71—
Feb 19, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 5, 2011FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 5, 2011FIMPFINAL DISPOSITION PROCESSED—
Apr 4, 2011FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 4, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 19, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 19, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 15, 2010ALIEASSIGNED TO LIE—
Sep 10, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 10, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 10, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 10, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 10, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 4, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 7, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 6, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 6, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 7, 2010RFNTREFUSAL PROCESSED BY IB—
Apr 6, 2010MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 5, 2010RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 5, 2010RFRRREFUSAL PROCESSED BY MPU—
Apr 5, 2010RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 4, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 2, 2010DOCKASSIGNED TO EXAMINER—
Apr 2, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 25, 2010REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance